pharma · Advanced Cancer · Advanced Solid Tumors · TCRT
Alaunos Therapeutics
Alaunos Therapeutics is a pharma organization headquartered in Houston, USA. It trades on NYSE under ticker TCRT. Primary therapeutic focus areas include Advanced Cancer, Advanced Solid Tumors, Solid Tumors, Melanoma, Me
8030 El Rio St, Houston, Texas 77054, US HQ
10 Employees
Public company Type
TCRT · NYSE Ticker
Company details
- Status
- Public
- HQ
- 8030 El Rio St, Houston, Texas 77054, US
- Employees
- 10
- Programs
- 34
- Drugs
- 12
- Patents
- 0
Ad-RTS-hIL-12
Phase 1 · mab · Glioblastoma Multiforme
Ad-RTS-hIL-12 for Glioblastoma Multiforme is a Phase 1 program (mab) at Alaunos Therapeutics with 1 ClinicalTrials.gov record(s).
Internal code ATI001-102
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Alaunos Therapeutics
- Phase
- Phase 1
- Modality
- mab
- Indication
- Glioblastoma Multiforme
- Status
- completed
- Trials
- 1